CClinicalTrials.gg
Status unknownNCT00484458Updated Oct 4, 2011

Wallis Stabilization System for Low Back Pain

A Phase 3 interventional study of Interspinous process and dynamic stabilization (Wallis System) and Total Disc Replacement in Low Back Pain, sponsored by Zimmer Spine. Status unknown at 11 sites in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2011-10-04.

Sponsored by Zimmer Spine · Phase 3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2011), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Phase 3
Study type
Interventional
Enrollment
340
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to demonstrate that the Wallis System (interspinous process implant) is equivalent to total disc replacement (TDR) for the treatment of mild to moderate degenerative disc disease (DDD) of the lumbar spine at the L4-L5 level.

This study will assess the safety and efficacy of the Wallis® System compared to commercially available lumbar TDR with respect to individual subject success rates at 24 months postoperative follow-up.

Study participants will receive all study related test articles and surgical procedures at no charge. Please scroll down to the "Locations" section to find a doctor in your area that is participating in this study. If you are interested in participating in this study and do not see a doctor in your area, please contact Jose Naveira at jose.naveira@abbottspine.com

02

Conditions studied

  • Low Back Pain

Keywords

  • Degenerative Disc Disease
  • Total Disc Replacement
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's planned enrollment of 340 is above the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Zimmer Spine is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18-60 (inclusive) and skeletally mature.
  • Diagnosis of mild to moderate DDD at L4-L5 as confirmed by radiography.
  • Minimum of six months of failed conservative treatment.
  • Pre-operative visual analog (VAS) low back pain score ≥ 40, on a scale of 100mm, with low back pain greater than left or right leg pain.
  • Preoperative baseline Oswestry Disability Index (ODI) score of ≥ 40 on a 100 point scale.
  • Physically and mentally able to comply with the protocol, including ability to read and complete required forms, and willing and able to adhere to the follow-up requirements of the protocol.
  • Voluntarily signs the patient informed consent form.
  • Patient is a surgical candidate for an anterior approach to the lumbar spine (\< 3 abdominal surgeries).

Exclusion criteria

Exclusion Criteria:

  • The investigator believes that the L1-L2, L2-L3, L3-L4, or L5-S1 level is symptomatic based upon objective evidence, e.g., radiograph, MRI, or discography.
  • Evidence of a prior fracture or trauma to the vertebral bodies at the affected level and/or the spinous processes at the L4-L5 or adjacent levels.
  • Osteoporosis or osteopenia or metabolic bone disease as confirmed by DEXA scan (T score \< -1.0). Female subjects older than 45 years of age (or post-menopausal women, history of oophorectomy, or family history of osteoporosis) and male subjects older than 55 years will undergo a pre-operative, dual energy x-ray absorptiometry (DEXA) of the lumbar spine. The DEXA will be used to identify subjects with an indication of osteoporosis, osteopenia or metabolic bone disease. Subjects with a T-score of less than -1.0 will be excluded from the study.
  • Congenital lumbar spinal stenosis.
  • Bony lumbar stenosis.
  • Extreme obesity, as defined by National Institutes of Health (NIH) Clinical Guidelines Body Mass Index (BMI > 40kg/m2).
  • A history of any surgical procedure intended to remove or alter the disc (e.g. discectomy, intradiscal electrothermal therapy (IDET) or enzymes), decompress (laminectomy) or fuse, either the index or adjacent levels.
  • Prior participation in study of any investigational spinal implant or investigational spinal treatment.
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
340 participants (estimated)

Study arms

  • Experimental
    1

    Wallis Stabilization System

    Device: Interspinous process and dynamic stabilization (Wallis System)

  • Active comparator
    2

    Total Disc Replacement

    Device: Total Disc Replacement

Interventions

  • DeviceInterspinous process and dynamic stabilization (Wallis System)

    Interspinous stabilization

  • DeviceTotal Disc Replacement

    Total disc

06

What researchers measure

Primary outcomes

  1. Non-inferior to commercially available lumber TDR after 24 months.

    Time frame: 24 months

07

Study locations

11 sites
  • Spine Source
    Beverly Hills, California 90212, United States
  • Core Orthopaedic Medical Center
    Encinitas, California 92024, United States
  • Boulder Neurosurgical Associates
    Boulder, Colorado 80504, United States
  • Denver Spine
    Greenwood Village, Colorado 80111, United States
  • Illinois Bone & Joint Institute
    Morton Grove, Illinois 60053, United States
  • Fort Wayne Orthopaedics
    Fort Wayne, Indiana 46804, United States
  • Medical University of South Carolina
    Charleston, North Carolina 29425, United States
  • Triangle Orthopaedic Associates, P.A.
    Durham, North Carolina 27302, United States
  • Lehigh Valley Hospital
    Allentown, Pennsylvania 18103, United States
  • University of Utah-Dept. of Neurosurgery-Dept. of Orthopedic Surgery
    Salt Lake City, Utah 84132, United States
  • Aurora BayCare Medical Center
    Green Bay, Wisconsin 54311, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 4, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00484458
Lead sponsor
Zimmer Spine
Collaborators
Zimmer Biomet
Responsible party
Sponsor
First posted
Jun 11, 2007
Start date
Jan 2007
Primary completion
Nov 2013 (estimated)
Completion
Nov 2014 (estimated)
Last update
Oct 4, 2011

Study contacts

John J. Regan, MD
principal investigator · Spine Source
Christopher Bergin, MD
principal investigator · Illinois Bone & Joint Institute

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion